Picture EBD Group ChinaBio Partnerting Forum 2021 651x80

Document › Details

PerkinElmer, Inc.. (12/10/18). "Press Release: PerkinElmer Appoints President & Chief Operating Officer". Waltham, MA.

	Organisation	PerkinElmer Inc. (NYSE: PKI)
	Group	PerkinElmer (Group)
	Organisation 2	GE Healthcare
	Group	General Electric (Group)
	Product	laboratory equipment and instruments
	Product 2	diagnostics (medical/biological)
	Person	Singh, Prahlad (PerkinElmer 201901– COO joined 2014 as President Diagnostics before GE Healthcare + Philips Healthcare)
	Person 2	Friel, Robert F. (PerkinElmer 200802– CEO before COO before President Life+Analytical joined 1999 as CFO)

Promotes Prahlad Singh to lead newly created role

PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that its board of directors has named Prahlad Singh president and chief operating officer, effective January 1, 2019. In his expanded position, Dr. Singh will have responsibility for both the Discovery and Analytical Solutions (DAS) and Diagnostics operating divisions of the Company. This change is being made to better facilitate synergies across the businesses to identify incremental growth opportunities, create operating efficiencies, and most importantly, accelerate the pace of innovation across the Company. Dr. Singh, along with the leaders of the Company’s corporate functions, will continue to report to Robert F. Friel, PerkinElmer’s chairman and chief executive officer.

“It is clear that technologies, applications, and customer needs are converging across DAS and Diagnostics as our customers’ businesses evolve and the lines between therapeutics, diagnostics, food, and digital health are intersecting,” said Friel. “The opportunities for DAS to become an enabler of the sciences of Diagnostics, and vice-versa, continue to grow. Prahlad’s track record of consistently driving strong results operationally, commercially and strategically makes him well qualified to take on this important role. I look forward to working with him as he helps both the Diagnostics and DAS businesses better innovate breakthrough solutions and exceptionally serve our customers, ultimately driving greater value across our markets.”

Dr. Singh joined PerkinElmer in 2014 as president of the Diagnostics business. He was elected an officer of PerkinElmer in 2016 and executive vice president in March 2018. Dr. Singh served as general manager of GE Healthcare’s Women’s Health Business, responsible for the mammography and bone densitometry businesses. Before that, Dr. Singh held senior executive level roles in strategy, business development and M&A at both GE and Philips Healthcare. From 1995 to 2007, he held leadership roles of increasing responsibility at DuPont Pharmaceuticals and subsequently Bristol Myers Squibb Medical Imaging which included managing the Asia Pacific and Middle East regions.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $2.3 billion in 2017, has about 11,000 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

Investor Relations
Tommy J. Thomas, 781-663-5889
tommy.thomas@perkinelmer.com

Media Relations
Brian Willinsky, 781-663-5728
brian.willinsky@perkinelmer.com

Record changed: 2019-01-29